Acute and long-term cardiovascular effects of coffee: Implications for coronary heart disease

Pharmacology and Therapeutics

Volumn 121, Issue 2, 2009, Pages 185-191

  Riksen, Niels P ^a   Rongen, Gerard A ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood pressure; Caffeine; Coffee; Coronary heart disease; Mechanisms

Indexed keywords

ADRENALIN; CAFFEINE; CATECHOLAMINE; CHOLESTEROL; HOMOCYSTEINE;

ACUTE DRUG ADMINISTRATION; ARTERIAL STIFFNESS; ATHEROSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CHRONIC DRUG ADMINISTRATION; COFFEE; CORONARY RISK; DIETARY INTAKE; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; HEART INFARCTION SIZE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; NON INSULIN DEPENDENT DIABETES MELLITUS; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; VASODILATATION;

BLOOD PRESSURE; CAFFEINE; CARDIOVASCULAR DISEASES; COFFEE; EPIDEMIOLOGIC METHODS; HEMODYNAMICS; HUMANS; RISK FACTORS; TIME FACTORS;

EID: 59849088128     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2008.10.006     Document Type: Review

References (103)

1. Ammon H.P., Bieck P.R., Mandalaz D., and Verspohl E.J. Adaptation of blood pressure to continuous heavy coffee drinking in young volunteers. A double-blind crossover study. Br J Clin Pharmacol 15 (1983) 701-706
2. Arion W.J., Canfield W.K., Ramos F.C., Schindler P.W., Burger H.J., Hemmerle H., et al. Chlorogenic acid and hydroxynitrobenzaldehyde: New inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 339 (1997) 315-322
3. Arnlov J., Vessby B., and Riserus U. Coffee consumption and insulin sensitivity. JAMA 291 (2004) 1199-1201
4. Aro A., Pietinen P., Uusitalo U., and Tuomilehto J. Coffee and tea consumption, dietary fat intake and serum cholesterol concentration of Finnish men and women. J Intern Med 226 (1989) 127-132
5. Barone J.J., and Roberts H.R. Caffeine consumption. Food Chem Toxicol 34 (1996) 119-129
6. Battram D.S., Arthur R., Weekes A., and Graham T.E. The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J Nutr 136 (2006) 1276-1280
7. Baylin A., Hernandez-Diaz S., Kabagambe E.K., Siles X., and Campos H. Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology 17 (2006) 506-511
8. Carson C.A., Caggiula A.W., Meilahn E.N., Matthews K.A., and Kuller L.H. Coffee consumption: Relationship to blood lipids in middle-aged women. Int J Epidemiol 23 (1994) 523-527
9. Casiglia E., Bongiovi S., Paleari C.D., Petucco S., Boni M., Colangeli G., et al. Haemodynamic effects of coffee and caffeine in normal volunteers: A placebo-controlled clinical study. J Intern Med 229 (1991) 501-504
10. Christensen B., Mosdol A., Retterstol L., Landaas S., and Thelle D.S. Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol-A randomized controlled trial. Am J Clin Nutr 74 (2001) 302-307
11. Cornelis M.C., and El-Sohemy A. Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol 18 (2007) 13-19
12. Cornelis M.C., El-Sohemy A., and Campos H. Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. Am J Clin Nutr 86 (2007) 240-244
13. Cornelis M.C., El-Sohemy A., Kabagambe E.K., and Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295 (2006) 1135-1141
14. de Vreede-Swagemakers J.J., Gorgels A.P., Weijenberg M.P., Dubois-Arbouw W.I., Golombeck B., van Ree J.W., et al. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. J Clin Epidemiol 52 (1999) 601-607
15. Donahue R.P., Orchard T.J., Stein E.A., and Kuller L.H. Lack of an association between coffee consumption and lipoprotein lipids and apolipoproteins in young adults: The Beaver County Study. Prev Med 16 (1987) 796-802
16. Farag N.H., Vincent A.S., McKey B.S., Whitsett T.L., and Lovallo W.R. Hemodynamic mechanisms underlying the incomplete tolerance to caffeine's pressor effects. Am J Cardiol 95 (2005) 1389-1392
17. Frary C.D., Johnson R.K., and Wang M.Q. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105 (2005) 110-113
18. Fredholm B.B. Are methylxanthine effects due to antagonism of endogenous adenosine?. Trends Pharmacol Sci 1 (1980) 129-132
19. Fredholm B.B., Battig K., Holmen J., Nehlig A., and Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51 (1999) 83-133
20. Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 4 (1993) 366-374
21. Grubben M.J., Boers G.H., Blom H.J., Broekhuizen R., de Jong R., van Rijt L., et al. Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: A randomized trial1. Am J Clin Nutr 71 (2000) 480-484
22. Happonen P., Voutilainen S., Tuomainen T.P., and Salonen J.T. Catechol-o-methyltransferase gene polymorphism modifies the effect of coffee intake on incidence of acute coronary events. PLoS ONE 1 (2006) e117
23. Hu G., Jousilahti P., Nissinen A., Bidel S., Antikainen R., and Tuomilehto J. Coffee consumption and the incidence of antihypertensive drug treatment in Finnish men and women. Am J Clin Nutr 86 (2007) 457-464
24. Jansen D.F., Nedeljkovic S., Feskens E.J., Ostojic M.C., Grujic M.Z., Bloemberg B.P., et al. Coffee consumption, alcohol use, and cigarette smoking as determinants of serum total and HDL cholesterol in two Serbian cohorts of the Seven Countries Study. Arterioscler Thromb Vasc Biol 15 (1995) 1793-1797
25. Jee S.H., He J., Appel L.J., Whelton P.K., Suh I., and Klag M.J. Coffee consumption and serum lipids: A meta-analysis of randomized controlled clinical trials. Am J Epidemiol 153 (2001) 353-362
26. Jee S.H., He J., Whelton P.K., Suh I., and Klag M.J. The effect of chronic coffee drinking on blood pressure: A meta-analysis of controlled clinical trials. Hypertension 33 (1999) 647-652
27. Johnston K.L., Clifford M.N., and Morgan L.M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: Glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 78 (2003) 728-733
28. Kabagambe E.K., Baylin A., and Campos H. Nonfatal acute myocardial infarction in Costa Rica: Modifiable risk factors, population-attributable risks, and adherence to dietary guidelines. Circulation 115 (2007) 1075-1081
29. Karatzis E., Papaioannou T.G., Aznaouridis K., Karatzi K., Stamatelopoulos K., Zampelas A., et al. Acute effects of caffeine on blood pressure and wave reflections in healthy subjects: Should we consider monitoring central blood pressure?. Int J Cardiol 98 (2005) 425-430
30. Kawachi I., Colditz G.A., and Stone C.B. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J 72 (1994) 269-275
31. Keijzers G.B., de Galan B.E., Tack C.J., and Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25 (2002) 364-369
32. Klag M.J., Wang N.Y., Meoni L.A., Brancati F.L., Cooper L.A., Liang K.Y., et al. Coffee intake and risk of hypertension: The Johns Hopkins precursors study. Arch Intern Med 162 (2002) 657-662
33. Klatsky A.L., Koplik S., Kipp H., and Friedman G.D. The confounded relation of coffee drinking to coronary artery disease. Am J Cardiol 101 (2008) 825-827
34. Kloner R.A. Natural and unnatural triggers of myocardial infarction. Prog Cardiovasc Dis 48 (2006) 285-300
35. Lancaster T., Muir J., and Silagy C. The effects of coffee on serum lipids and blood pressure in a UK population. J R Soc Med 87 (1994) 506-507
36. Lindahl B., Johansson I., Huhtasaari F., Hallmans G., and Asplund K. Coffee drinking and blood cholesterol-Effects of brewing method, food intake and life style. J Intern Med 230 (1991) 299-305
37. Little J.A., Shanoff H.M., Csima A., Toronto M.A., and Yano R. Coffee and serum-lipids in coronary heart-disease. Lancet 1 (1966) 732-734
38. Lopez-Garcia E., van Dam R.M., Li T.Y., Rodriguez-Artalejo F., and Hu F.B. The relationship of coffee consumption with mortality. Ann Intern Med 148 (2008) 904-914
39. Lopez-Garcia E., van Dam R.M., Qi L., and Hu F.B. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 84 (2006) 888-893
40. Loscalzo J. Homocysteine trials-Clear outcomes for complex reasons. N Engl J Med 354 (2006) 1629-1632
41. Lovallo W.R., Wilson M.F., Vincent A.S., Sung B.H., McKey B.S., and Whitsett T.L. Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption. Hypertension 43 (2004) 760-765
42. Mahmud A., and Feely J. Acute effect of caffeine on arterial stiffness and aortic pressure waveform. Hypertension 38 (2001) 227-231
43. Miller T.D., Christian T.F., Hopfenspirger M.R., Hodge D.O., Gersh B.J., and Gibbons R.J. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 92 (1995) 334-341
44. Mukamal K.J., Maclure M., Muller J.E., Sherwood J.B., and Mittleman M.A. Caffeinated coffee consumption and mortality after acute myocardial infarction. Am Heart J 147 (2004) 999-1004
45. Myers M.G., and Basinski A. Coffee and coronary heart disease. Arch Intern Med 152 (1992) 1767-1772
46. Nieto F.J., Comstock G.W., Chambless L.E., and Malinow R.M. Coffee consumption and plasma homocyst(e)ine: Results from the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 66 (1997) 1475-1477
47. Noordzij M., Uiterwaal C.S., Arends L.R., Kok F.J., Grobbee D.E., and Geleijnse J.M. Blood pressure response to chronic intake of coffee and caffeine: A meta-analysis of randomized controlled trials. J Hypertens 23 (2005) 921-928
48. Notarius C.F., Atchison D.J., Rongen G.A., and Floras J.S. Effect of adenosine receptor blockade with caffeine on sympathetic response to handgrip exercise in heart failure. Am J Physiol Heart Circ Physiol 281 (2001) H1312-H1318
49. Nurminen M.L., Niittynen L., Korpela R., and Vapaatalo H. Coffee, caffeine and blood pressure: A critical review. Eur J Clin Nutr 53 (1999) 831-839
50. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., and Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
51. Olthof M.R., Hollman P.C., Zock P.L., and Katan M.B. Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am J Clin Nutr 73 (2001) 532-538
52. Panagiotakos D.B., Pitsavos C., Zampelas A., Zeimbekis A., Chrysohoou C., Papademetriou L., et al. The association between coffee consumption and plasma total homocysteine levels: The "ATTICA" study. Heart Vessels 19 (2004) 280-286
53. Papamichael C.M., Aznaouridis K.A., Karatzis E.N., Karatzi K.N., Stamatelopoulos K.S., Vamvakou G., et al. Effect of coffee on endothelial function in healthy subjects. The role of caffeine. Clin Sci (Lond) 109 (2005) 55-60
54. Patti G., Pasceri V., Colonna G., Miglionico M., Fischetti D., Sardella G., et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: Results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 49 (2007) 1272-1278
55. Paul O., Lepper M.H., Phelan W.H., Dupertuis G.W., MacMillan A., McKean H., et al. A longitudinal study of coronary heart disease. Circulation 28 (1963) 20-31
56. Paynter N.P., Yeh H.C., Voutilainen S., Schmidt M.I., Heiss G., Folsom A.R., et al. Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: The atherosclerosis risk in communities study. Am J Epidemiol 164 (2006) 1075-1084
57. Pereira M.A., Parker E.D., and Folsom A.R. Coffee consumption and risk of type 2 diabetes mellitus: An 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 166 (2006) 1311-1316
58. Pietinen P., Aro A., Tuomilehto J., Uusitalo U., and Korhonen H. Consumption of boiled coffee is correlated with serum cholesterol in Finland. Int J Epidemiol 19 (1990) 586-590
59. Pincomb G.A., Lovallo W.R., Passey R.B., Whitsett T.L., Silverstein S.M., and Wilson M.F. Effects of caffeine on vascular resistance, cardiac output and myocardial contractility in young men. Am J Cardiol 56 (1985) 119-122
60. Riksen N.P., Franke B., van den Broek P., Smits P., and Rongen G.A. The 1976C > T polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivo. Pharmacogenet Genomics 17 (2007) 551-554
61. Riksen N.P., Hausenloy D.J., and Yellon D.M. Wake up and smell the coffee: Yet another no go for cardiac patients?. Cardiovasc Drugs Ther 22 (2008) 257-259
62. Riksen N.P., Zhou Z., Oyen W.J., Jaspers R., Ramakers B.P., Brouwer R.M., et al. Caffeine prevents protection in two human models of ischemic preconditioning. J Am Coll Cardiol 48 (2006) 700-707
63. Robertson D., Frolich J.C., Carr R.K., Watson J.T., Hollifield J.W., Shand D.G., et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298 (1978) 181-186
64. Robertson D., Wade D., Workman R., Woosley R.L., and Oates J.A. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67 (1981) 1111-1117
65. Rongen G.A., Brooks S.C., Ando S., Notarius C.F., and Floras J.S. Caffeine abstinence augments the systolic blood pressure response to adenosine in humans. Am J Cardiol 81 (1998) 1382-1385
66. Rongen G.A., Floras J.S., Lenders J.W., Thien T., and Smits P. Cardiovascular pharmacology of purines. Clin Sci (Lond) 92 (1997) 13-24
67. Rosner S.A., Akesson A., Stampfer M.J., and Wolk A. Coffee consumption and risk of myocardial infarction among older Swedish women. Am J Epidemiol 165 (2007) 288-293
68. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med 340 (1999) 115-126
69. Sanada S., Asanuma H., Minamino T., Node K., Takashima S., Okuda H., et al. Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase. Circulation 110 (2004) 2143-2149
70. Schulze M.B., Manson J.E., Ludwig D.S., Colditz G.A., Stampfer M.J., Willett W.C., and Hu F.B. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 292 (2004) 927-934
71. Silletta M.G., Marfisi R., Levantesi G., Boccanelli A., Chieffo C., Franzosi M., et al. Coffee consumption and risk of cardiovascular events after acute myocardial infarction: Results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial. Circulation 116 (2007) 2944-2951
72. Smits P., Boekema P., De Abreu R., Thien T., and van 't Laar A. Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol 10 (1987) 136-143
73. Smits P., Lenders J.W., and Thien T. Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther 48 (1990) 410-418
74. Smits P., Pieters G., and Thien T. The role of epinephrine in the circulatory effects of coffee. Clin Pharmacol Ther 40 (1986) 431-437
75. Smits P., Thien T., and van 't Laar A. The cardiovascular effects of regular and decaffeinated coffee. Br J Clin Pharmacol 19 (1985) 852-854
76. Smits P., Thien T., and van 't Laar A. Circulatory effects of coffee in relation to the pharmacokinetics of caffeine. Am J Cardiol 56 (1985) 958-963
77. Sofi F., Conti A.A., Gori A.M., Eliana Luisi M.L., Casini A., Abbate R., et al. Coffee consumption and risk of coronary heart disease: A meta-analysis. Nutr Metab Cardiovasc Dis 17 (2007) 209-223
78. Stolzenberg-Solomon R.Z., Miller III E.R., Maguire M.G., Selhub J., and Appel L.J. Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population. Am J Clin Nutr 69 (1999) 467-475
79. Strandhagen E., and Thelle D.S. Filtered coffee raises serum cholesterol: Results from a controlled study. Eur J Clin Nutr 57 (2003) 1164-1168
80. Strandhagen E., Zetterberg H., Aires N., Palmer M., Rymo L., Blennow K., et al. The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: A randomized placebo controlled study. Int J Mol Med 13 (2004) 811-815
81. Strandhagen E., Zetterberg H., Aires N., Palmer M., Rymo L., Blennow K., et al. The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee. Lipids Health Dis 3 (2004) 26
82. Sutton-Tyrrell K., Najjar S.S., Boudreau R.M., Venkitachalam L., Kupelian V., Simonsick E.M., et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111 (2005) 3384-3390
83. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 288 (2002) 2015-2022
84. Thelle D.S., Heyden S., and Fodor J.G. Coffee and cholesterol in epidemiological and experimental studies. Atherosclerosis 67 (1987) 97-103
85. Uiterwaal C.S., Verschuren W.M., Bueno-de-Mesquita H.B., Ocke M., Geleijnse J.M., Boshuizen H.C., et al. Coffee intake and incidence of hypertension. Am J Clin Nutr 85 (2007) 718-723
86. Urgert R., and Katan M.B. The cholesterol-raising factor from coffee beans. Annu Rev Nutr 17 (1997) 305-324
87. van Dam R.M., Dekker J.M., Nijpels G., Stehouwer C.D., Bouter L.M., and Heine R.J. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: The Hoorn Study. Diabetologia 47 (2004) 2151-2159
88. van Dam R.M., and Feskens E.J. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360 (2002) 1477-1478
89. van Dam R.M., and Hu F.B. Coffee consumption and risk of type 2 diabetes: A systematic review. JAMA 294 (2005) 97-104
90. van Dam R.M., Willett W.C., Manson J.E., and Hu F.B. Coffee, caffeine, and risk of type 2 diabetes: A prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 29 (2006) 398-403
91. van Woudenbergh G.J., Vliegenthart R., van Rooij F.J.A., Hofman A., Oudkerk M., Witteman J.C.M., et al. Coffee consumption and coronary calcification: The Rotterdam coronary calcification study. Arterioscler Thromb Vasc Biol 28 (2008) 1018-1023
92. Verhoef P., Pasman W.J., van Vliet T., Urgert R., and Katan M.B. Contribution of caffeine to the homocysteine-raising effect of coffee: A randomized controlled trial in humans. Am J Clin Nutr 76 (2002) 1244-1248
93. Vlachopoulos C., Hirata K., and O'Rourke M.F. Effect of caffeine on aortic elastic properties and wave reflection. J Hypertens 21 (2003) 563-570
94. Vlachopoulos C., Kosmopoulou F., Panagiotakos D., Ioakeimidis N., Alexopoulos N., Pitsavos C., et al. Smoking and caffeine have a synergistic detrimental effect on aortic stiffness and wave reflections. J Am Coll Cardiol 44 (2004) 1911-1917
95. Vlachopoulos C., Panagiotakos D., Ioakeimidis N., Dima I., and Stefanadis C. Chronic coffee consumption has a detrimental effect on aortic stiffness and wave reflections. Am J Clin Nutr 81 (2005) 1307-1312
96. Weggemans R.M., Zock P.L., Ordovas J.M., Pedro-Botet J., and Katan M.B. Apoprotein E genotype and the response of serum cholesterol to dietary fat, cholesterol and cafestol. Atherosclerosis 154 (2001) 547-555
97. Weggemans R.M., Zock P.L., Ordovas J.M., Ramos-Galluzzi J., and Katan M.B. Genetic polymorphisms and lipid response to dietary changes in humans. Eur J Clin Invest 31 (2001) 950-957
98. Williams C.J., Fargnoli J.L., Hwang J.J., van Dam R.M., Blackburn G.L., Hu F.B., et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: A prospective cohort study. Diabetes Care 31 (2008) 504-507
99. Wilson P.W., Garrison R.J., Kannel W.B., McGee D.L., and Castelli W.P. Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham Study. Arch Intern Med 149 (1989) 1169-1172
100. Winkelmayer W.C., Stampfer M.J., Willett W.C., and Curhan G.C. Habitual caffeine intake and the risk of hypertension in women. JAMA 294 (2005) 2330-2335
101. Ye Y., Abu Said G., Lin Y., Manickavasagam S., Hughes M., McAdoo D., et al. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat. Cardiovasc Drugs Ther 22 (2008) 275-282
102. Yellon D.M., and Downey J.M. Preconditioning the myocardium: From cellular physiology to clinical cardiology. Physiol Rev 83 (2003) 1113-1151
103. Zampelas A., Panagiotakos D.B., Pitsavos C., Chrysohoou C., and Stefanadis C. Associations between coffee consumption and inflammatory markers in healthy persons: The ATTICA study. Am J Clin Nutr 80 (2004) 862-867